美團買藥居家快檢已在上海開通 首批試點已完成檢測訂單
《證券時報》報道,此前在北京、廣州陸續開通的「美團買藥居家快檢」服務已在上海市浦東區、寶山區等地開通,首批試點的門店已在今日(11日)上午陸續接到並完成檢測訂單,預計本周該服務持續擴大覆蓋範圍。
美團買藥方面介紹,上海居家快檢的第一單於門店上線後8分鐘產生,用戶是從美團的看病買藥頻道看到有該服務就直接下單。美團買藥有關負責人介紹,由於服務剛剛上線,該位率先下單的用戶在上午11時左右就完成取樣環節,預計下午約1時可收到檢測結果。
目前,居家快檢可以通過兩種方式下單:第一種是在美團、美團外賣App的「看病買藥」頻道,搜索「居家快檢」進入檢測專題頁,點擊立即檢測後進入購買頁面;第二種通過微信搜索「美團買藥」小程序或掃描小程序二維碼,進入下單頁面。據了解,美團買藥居家快檢一次性可以檢測甲流、乙流、支原體等12種近期常見的呼吸道感染病毒或細菌,可比抗原檢測早兩天發現病毒。
截至目前,美團買藥與上海華氏、第一醫藥等連鎖藥店聯手,已累計上線78家醫保藥店(僅限OTC),支持本地醫保個賬線上支付,覆蓋黃浦、徐匯、靜安等8個城區,未來服務範圍逐步擴大至全城。
今年以來,美團買藥在上海市的創新舉措頗多。從24小時藥店覆蓋、到與部分連鎖開展醫保支付,再到此次開設居家快檢服務,已基本形成「居家檢測-線上問診-24小時買藥-醫保支付」的線上居家健康服務自我管理閉環,給小病小痛、慢病人群帶來更加便捷的服務模式。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.